The ZIIR element of the Epstein-Barr virus BZLF1 promoter plays a central role in establishment and maintenance of viral latency

Journal of Virology

Volumn 85, Issue 10, 2011, Pages 5081-5090

  Yu, Xianming ^a   McCarthy, Patrick J ^a   Lim, Hui Jun ^a   Iempridee, Tawin ^a   Kraus, Richard J ^a   Gorlen, Daniel A ^a   Mertz, Janet E ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMEDIATE EARLY PROTEIN; IMMEDIATE EARLY PROTEIN BZLF1; IMMEDIATE EARLY PROTEIN EAD; IMMEDIATE EARLY PROTEIN RTA; PROTEIN KINASE C; UNCLASSIFIED DRUG;

ARTICLE; B LYMPHOCYTE; BINDING SITE; BZLF1 GENE; CELL STRAIN HEK293; CONTROLLED STUDY; DNA REPLICATION; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL LINE; NONHUMAN; NUCLEIC ACID BASE SUBSTITUTION; PRIORITY JOURNAL; PROMOTER REGION; SIGNAL TRANSDUCTION; VIRUS GENE; VIRUS GENOME; VIRUS LATENCY; VIRUS REACTIVATION; VIRUS REPLICATION; VIRUS STRAIN; ZIIR ELEMENT;

B-LYMPHOCYTES; CELL LINE; HERPESVIRUS 4, HUMAN; HUMANS; MUTAGENESIS, SITE-DIRECTED; PROMOTER REGIONS, GENETIC; TRANS-ACTIVATORS; VIRUS LATENCY;

HUMAN HERPESVIRUS 4;

EID: 79955417149     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02615-10     Document Type: Article

References (57)

1. Altmann, M., and W. Hammerschmidt. 2005. Epstein-Barr virus provides a new paradigm: a requirement for the immediate inhibition of apoptosis. PLoS Biol. 3:2148-2157.
2. Altmann, M., et al. 2006. Transcriptional activation by EBV nuclear antigen 1 is essential for the expression of EBV's transforming genes. Proc. Natl. Acad. Sci. U. S. A. 103:14188-14193.
3. Angel, P., et al. 1987. Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor. Cell 49:729-739.
4. Baumann, M., et al. 1998. Activation of the Epstein-Barr virus transcription factor BZLF1 by 12-O-tetradecanoylphorbol-13-acetate-induced phosphorylation. J. Virol. 72:8105-8114.
5. Bhende, P. M., S. J. Dickerson, X. Sun, W. H. Feng, and S. C. Kenney. 2007. X-box-binding protein 1 activates lytic Epstein-Barr virus gene expression in combination with protein kinase D. J. Virol. 81:7363-7370.
6. Borras, A. M., J. L. Strominger, and S. H. Speck. 1996. Characterization of the ZI domains in the Epstein-Barr virus BZLF1 gene promoter: role in phorbol ester induction. J. Virol. 70:3894-3901.
7. Bryant, H., and P. J. Farrell. 2002. Signal transduction and transcription factor modification during reactivation of Epstein-Barr virus from latency. J. Virol. 76:10290-10298.
8. Cahir-McFarland, E., and E. Kieff. 2005. Epstein-Barr virus latent infection membrane protein one, p. 553-570. In E. S. Robertson (ed.), Epstein-Barr virus. Caister Academic Press, Norwich, United Kingdom.
9. 2+-dependent switch from latency to viral replication. J. Virol. 71:6560-6567.
10. Chodosh, L. A. 1996. UV crosslinking of proteins to nucleic acids, p. 12.5.1. In F. M. Ausubel, R. Brent, R. E. Kinston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl (ed.), Current protocols in molecular biology. John Wiley & Sons, Inc., New York, NY.
11. Countryman, J., and G. Miller. 1985. Activation of expression of latent Epstein-Barr herpesvirus after gene transfer with a small cloned subfragment of heterogeneous viral DNA. Proc. Natl. Acad. Sci. U. S. A. 82:4085-4089.
12. Daigle, D., et al. 2010. Upregulation of STAT3 marks Burkitt lymphoma cells refractory to Epstein-Barr virus lytic cycle induction by HDAC inhibitors. J. Virol. 84:993-1004.
13. Delecluse, H. J., T. Hilsendegen, D. Pich, R. Zeidler, and W. Hammer-schmidt. 1998. Propagation and recovery of intact, infectious Epstein-Barr virus from prokaryotic to human cells. Proc. Natl. Acad. Sci. U. S. A. 95:8245-8250.
14. Duellman, S. J., and R. R. Burgess. 2009. Antigen-binding properties of monoclonal antibodies reactive with EBNA1 and use in immunoaffinity chromatography. PLoS One 4:e4614.
15. Ellis, A. L., Z. Wang, X. Yu, and J. E. Mertz. 2010. Either ZEB1 or ZEB2/SIP1 can play a central role in regulating the Epstein-Barr virus latent-lytic switch in a cell-type-specific manner. J. Virol. 84:6139-6152.
16. Ellis-Connell, A. L., T. Iempridee, I. Xu, and J. E. Mertz. 2010. Cellular microRNAs 200b and 429 regulate the Epstein-Barr virus switch between latency and lytic replication. J. Virol. 84:10329-10343.
17. Feederle, R., et al. 2000. The Epstein-Barr virus lytic program is controlled by the co-operative functions of two transactivators. EMBO J. 19:3080-3089.
18. Feng, W. H., et al. 2007. ZEB1 and c-Jun levels contribute to the establishment of highly lytic Epstein-Barr virus infection in gastric AGS cells. J. Virol. 81:10113-10122.
19. Flamand, L., and J. Menezes. 1996. Cyclic AMP-responsive element-dependent activation of Epstein-Barr virus zebra promoter by human herpesvirus 6. J. Virol. 70:1784-1791.
20. Flemington, E., and S. H. Speck. 1990. Identification of phorbol ester response elements in the promoter of Epstein-Barr virus putative lytic gene BZLF1. J. Virol. 64:1217-1226.
21. Gao, X., K. Ikuta, M. Tajima, and T. Sairenji. 2001. 12-O-Tetradecanoyl-phorbol-13-acetate induces Epstein-Barr virus reactivation via NF-KB and AP-1 as regulated by protein kinase C and mitogen-activated protein kinase. Virology 286:91-99.
22. Gradoville, L., D. Kwa, A. El-Guindy, and G. Miller. 2002. Protein kinase C-independent activation of the Epstein-Barr virus lytic cycle. J. Virol. 76: 5612-5626.
23. Hammerschmidt, W., and B. Sugden. 1988. Identification and characterization of oriLyt, a lytic origin of DNA replication of Epstein-Barr virus. Cell 55:427-433.
24. Huang, J., et al. 2006. Contribution of C/EBP proteins to Epstein-Barr virus lytic gene expression and replication in epithelial cells. J. Virol. 80:1098-1109.
25. Hudewentz, J., G. W. Bornkamm, and H. zur Hausen. 1980. Effect of the diterpene ester TPA on Epstein-Barr virus antigen and DNA synthesis in producer and nonproducer cell lines. Virology 100:175-178.
26. Israel, B. F., and S. C. Kenney. 2005. EBV lytic infection, p. 571-611. In E. S. Robertson (ed.), Epstein-Barr virus. Caister Academic Press, Norwich, United Kingdom.
27. Kalla, M., A. Schmeinck, M. Bergbauer, D. Pich, and W. Hammerschmidt. 2010. AP-1 homolog BZLF1 of Epstein-Barr virus has two essential functions dependent on the epigenetic state of the viral genome. Proc. Natl. Acad. Sci. U. S. A. 107:850-855.
28. Kieff, E., and A. B. Rickinson. 2007. Epstein-Barr virus and its replication, p. 2603-2654. In D. M. Knipe, and P. M. Howley (ed.), Fields virology, 5th ed., vol. 2. Lippincott/Williams & Wilkins Co., Philadelphia, PA.
29. Kraus, R. J., S. J. Mirocha, H. M. Stephany, J. R. Puchalski, and J. E. Mertz. 2001. Identification of a novel element involved in regulation of the lytic switch BZLF1 gene promoter of Epstein-Barr virus. J. Virol. 75:867-877.
30. Kraus, R. J., J. G. Perrigoue, and J. E. Mertz. 2003. ZEB negatively regulates the lytic-switch BZLF1 gene promoter of Epstein-Barr virus. J. Virol. 77:199-207.
31. Lin, Z., and E. K. Flemington. 2010. Regulation of EBV latency by viral lytic proteins, p. 167-192. In E. S. Robertson (ed.), Epstein-Barr virus: latency and transformation. Caister Academic Press, Norwich, United Kingdom.
32. Liu, P., S. Liu, and S. H. Speck. 1998. Identification of a negative cis element within the ZII domain of the Epstein-Barr virus lytic switch BZLF1 gene promoter. J. Virol. 72:8230-8239.
33. Liu, S., A. M. Borras, P. Liu, G. Suske, and S. H. Speck. 1997. Binding of the ubiquitous cellular transcription factors Sp1 and Sp3 to the ZI domains in the Epstein-Barr virus lytic switch BZLF1 gene promoter. Virology 228:11-18.
34. Liu, S., P. Liu, A. Borras, T. Chatila, and S. H. Speck. 1997. Cyclosporin A-sensitive induction of the Epstein-Barr virus lytic switch is mediated via a novel pathway involving a MEF2 family member. EMBO J. 16:143-153.
35. Montalvo, E. A., M. Cottam, S. Hill, and Y.-C. J. Wang. 1995. YY1 binds to and regulates cis-acting negative elements in the Epstein-Barr virus BZLF1 promoter. J. Virol. 69:4158-4165.
36. Montalvo, E. A., Y. Shi, T. E. Shenk, and A. J. Levine. 1991. Negative regulation of the BZLF1 promoter of Epstein-Barr virus. J. Virol. 65:3647-3655.
37. Moorman, N. J., D. O. Willer, and S. H. Speck. 2003. The gammaherpesvirus 68 latency-associated nuclear antigen homolog is critical for the establishment of splenic latency. J. Virol. 77:10295-10303.
38. Neuhierl, B., R. Feederle, W. Hammerschmidt, and H. J. Delecluse. 2002. Glycoprotein gp110 of Epstein-Barr virus determines viral tropism and efficiency of infection. Proc. Natl. Acad. Sci. U. S. A. 99:15036-15041.
39. Raab-Traub, N., and K. Flynn. 1986. The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell 47:883- 889.
40. Reyland, M. E. 2009. Protein kinase C isoforms: multi-functional regulators of cell life and death. Front. Biosci. 14:2386-2399.
41. Rickinson, A. B., and E. Kieff. 2007. Epstein-Barr virus and its replication. p. 2656-2700. In D. M. Knipe, and P. M. Howley (ed.), Fields virology, 5th ed., vol. 2. Lippincott/Williams & Wilkins Co., Philadelphia, PA.
42. Schwarzmann, F., et al. 1994. Negatively cis-acting elements in the distal part of the promoter of Epstein-Barr virus trans-activator gene BZLF1. J. Gen. Virol. 75:1999-2006.
43. Smith, G. A., and L. W. Enquist. 1999. Construction and transposon mutagenesis in Escherichia coli of a full-length infectious clone of Pseudorabies virus, an alphaherpesvirus. J. Virol. 73:6405-6414.
44. Speck, S. H. 2005. Regulation of EBV latency-associated gene expression, p. 403-427. In E. S. Robertson (ed.), Epstein-Barr virus. Caister Academic Press, Norwich, United Kingdom.
45. Speck, S. H., T. Chatila, and E. Flemington. 1997. Reactivation of Epstein-Barr virus: regulation and function of the BZLF1 gene. Trends Microbiol. 5:399-405.
46. Sun, C. C., and D. A. Thorley-Lawson. 2007. Plasma cell-specific transcription factor XBP-1s binds to and transactivates the Epstein-Barr virus BZLF1 promoter. J. Virol. 81:13566-13577.
47. Swaminathan, S., et al. 2001. Rapid engineering of bacterial artificial chromosomes using oligonucleotides. Genesis 29:14-21.
48. Thomas, C, A. Dankesreiter, H. Wolf, and F. Schwarzmann. 2003. The BZLF1 promoter of Epstein-Barr virus is controlled by E box-/HI-motif-binding factors during virus latency. J. Gen. Virol. 84:959-964.
49. Toullec, D., et al. 1991. The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J. Biol. Chem. 266:15771-15781.
50. Wang, Y.-C. J., J.-M. Huang, and E. A. Montalvo. 1997. Characterization of proteins binding to the ZII element in the Epstein-Barr virus BZLF1 promoter: transactivation by ATF1. Virology 227:323-330.
51. Weigel, R., D. K. Fischer, L. Heston, and G. Miller. 1985. Constitutive expression of Epstein-Barr virus-encoded RNAs and nuclear antigen during latency and after induction of Epstein-Barr virus replication. J. Virol. 53: 254-259.
52. Wen, W., et al. 2007. Epstein-Barr virus BZLF1 gene, a switch from latency to lytic infection, is expressed as an immediate-early gene after primary infection of B lymphocytes. J. Virol. 81:1037-1042.
53. Wu, F. Y., et al. 2004. CCAAT/enhancer binding protein a binds to the Epstein-Barr virus (EBV) ZTA protein through oligomeric interactions and contributes to cooperative transcriptional activation of the ZTA promoter through direct binding to the ZII and ZIIIB motifs during induction of the EBV lytic cycle. J. Virol. 78:4847-4865.
54. Yu, X., Z. Wang, and J. E. Mertz. 2007. ZEB1 regulates the latent-lytic switch in infection by Epstein-Barr virus. PLoS Pathog. 3:e194.
55. Zetterberg, H., and L. Rymo. 2005. EBNA2 transcriptional regulation in EBV latency, p. 439-462. In E. S. Robertson (ed.), Epstein-Barr virus, Caister Academic Press, Norwich, United Kingdom.
56. Zhang, Q., Y.-C. J. Wang, and E. A. Montalvo. 1999. S|jibp-2 represses the Epstein-Barr virus lytic switch promoter. Virology 255:160-170.
57. zur Hausen, H., F. J. O'Neill, U. K. Freese, and E. Hecker. 1978. Persisting oncogenic herpesvirus induced by the tumour promoter TPA. Nature 272: 373-375.